Editas Medicine, Inc. (EDIT)

Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	95.83	123.65	141.52	203.52	139.68	238.18
Short-Term Investments	169.26	199.46	202.75	296.33	262.43	218.96
Cash & Short-Term Investments	265.09	323.11	344.27	499.85	402.11	457.14
Cash Growth	-24.18%	-6.15%	-31.12%	24.31%	-12.04%	23.90%
Accounts Receivable	0.13	10.19	5.15	0.27	6.05	0.42
Receivables	0.13	10.19	5.15	0.27	6.05	0.42
Prepaid Expenses	5.93	7.53	7.34	7.2	10.93	6.29
Total Current Assets	271.14	340.83	356.75	507.31	419.09	463.84
Property, Plant & Equipment	51.15	45.71	59.22	43.29	39.15	39.65
Long-Term Investments	-	104.02	93.1	120.07	109.66	3.67
Other Long-Term Assets	5.28	8.59	5.25	6.81	4.7	1.73
Total Assets	327.57	499.15	514.32	677.48	572.6	508.89
Accounts Payable	12.49	8.27	9.51	5.05	6.41	5.84
Accrued Expenses	28.79	34.56	31.3	20.19	24.05	10.7
Current Portion of Leases	16.39	12.16	11.08	10.31	6.81	5.8
Current Unearned Revenue	14.68	8.22	8.22	11.33	20.94	23.51
Other Current Liabilities	-	-	-	-	-	14.1
Total Current Liabilities	72.35	63.22	60.11	46.88	58.21	59.96
Long-Term Leases	22.1	24.37	32.86	16.07	19.32	23.28
Long-Term Unearned Revenue	54.2	60.67	60.67	60.89	73.98	163.21
Other Long-Term Liabilities	3.28	1.8	-	-	27.5	0
Total Liabilities	151.93	150.06	153.64	123.84	179.02	246.45
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,598	1,580	1,442	1,412	1,059	811.55
Retained Earnings	-1,423	-1,231	-1,078	-857.7	-665.2	-549.22
Comprehensive Income & Other	0.52	0.2	-3.6	-0.49	-0.05	0.11
Total Common Equity	175.63	349.1	360.68	553.64	393.59	262.44
Shareholders' Equity	175.63	349.1	360.68	553.64	393.59	262.44
Total Liabilities & Equity	327.57	499.15	514.32	677.48	572.6	508.89
Total Debt	38.49	36.54	43.95	26.38	26.14	29.08
Net Cash (Debt)	226.6	390.6	393.43	593.54	485.64	428.06
Net Cash Growth	-44.97%	-0.72%	-33.72%	22.22%	13.45%	27.19%
Net Cash Per Share	2.76	5.14	5.73	8.78	8.29	8.56
Filing Date Shares Outstanding	82.55	81.81	67.47	68.46	67.24	54.29
Total Common Shares Outstanding	82.54	81.77	67.35	68.44	62.56	53.97
Working Capital	198.79	277.61	296.64	460.43	360.88	403.88
Book Value Per Share	2.13	4.27	5.36	8.09	6.29	4.86
Tangible Book Value	175.63	349.1	360.68	553.64	393.59	262.44
Tangible Book Value Per Share	2.13	4.27	5.36	8.09	6.29	4.86
Machinery	-	26.37	25.55	22.72	19.17	15.6
Construction In Progress	-	2.06	1.57	1.53	0.86	1.34
Leasehold Improvements	-	9.65	9.76	8.16	4.97	1.04

Source: S&P Capital IQ. Standard template. Financial Sources.